08045804946
Send Inquiry
Atazanavi and Ritonavir Tablet IP
2200.0 INR/Bottle
Product Details:
- Origin India
- Indication Antiretroviral therapy, used in the treatment of HIV infection
- Dosage Form Tablet
- Salt Composition Atazanavir 300 mg + Ritonavir 100 mg
- Enzyme Types Not applicable (antiviral drugs)
- Feature Fixed dose combination of HIV protease inhibitors
- Ingredients Atazanavir, Ritonavir, Excipients
- Click to View more
X
Atazanavi and Ritonavir Tablet IP Price And Quantity
- 5 Number
- 2200.0 INR/Bottle
Atazanavi and Ritonavir Tablet IP Product Specifications
- Fixed dose combination of HIV protease inhibitors
- Atazanavir 300 mg + Ritonavir 100 mg
- 24 months Months
- Not applicable (antiviral drugs)
- Atazanavir, Ritonavir, Excipients
- HIV treatment as part of combination antiretroviral therapy
- Tablet
- Yellow, capsule-shaped, film-coated tablets
- India
- Antiretroviral therapy, used in the treatment of HIV infection
- Store below 30C. Protect from moisture.
Atazanavi and Ritonavir Tablet IP Trade Information
- Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Australia, Central America, North America, Asia, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India, South India, Central India, North India, Meghalaya, Manipur, Andhra Pradesh, Bihar, Goa, Punjab, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Jammu and Kashmir, Madhya Pradesh, Maharashtra, Nagaland, Rajasthan, Mizoram, Delhi, Dadra and Nagar Haveli, West India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Chandigarh, Daman and Diu, Jharkhand, Odisha, Assam, Sikkim, Tamil Nadu, Telangana, Tripura, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal
Product Description
Experience the dominant and sterling efficacy of Atazanavi & Ritonavir Tablet IP by Emcure Pharmaceuticals Ltd., acclaimed across various markets for its formidable impact in HIV treatment. This promotion delivers a best price on a fixed-dose combination of HIV protease inhibitors-atazanavir (300 mg) and ritonavir (100 mg)-designed to streamline antiretroviral therapy. Each prescription-only bottle contains 30 yellow, capsule-shaped, film-coated tablets. For optimal results, administer orally under strict medical supervision. Keep the product tightly closed in its original packaging below 30C to preserve quality.
Formidable HIV Therapy: Features & Special Instructions
Atazanavi and Ritonavir Tablet IP features a fixed-dose combination of potent protease inhibitors, offering a dominant strategy in HIV management. Special features include simple, once-daily administration, designed for superior patient adherence. Direction of use: Take orally as directed by your healthcare professional, integrating this therapy into combination antiretroviral regimens. Store in its original container, tightly sealed, at temperatures below 30C, and away from moisture to maintain its sterling quality.
Leading Supply: Export Markets, Shipment & Trade Details
Atazanavi and Ritonavir Tablet IP enjoys robust demand in both domestic and international markets. Shipped goods are processed efficiently from our main FOB ports, with a strong supply ability catering to exporters, dealers, and wholesalers. Our comprehensive charge structure offers competitive rates within the domestic marketplace, consolidating our position as a formidable player in pharmaceutical logistics and distribution for critical HIV medications.
Formidable HIV Therapy: Features & Special Instructions
Atazanavi and Ritonavir Tablet IP features a fixed-dose combination of potent protease inhibitors, offering a dominant strategy in HIV management. Special features include simple, once-daily administration, designed for superior patient adherence. Direction of use: Take orally as directed by your healthcare professional, integrating this therapy into combination antiretroviral regimens. Store in its original container, tightly sealed, at temperatures below 30C, and away from moisture to maintain its sterling quality.
Leading Supply: Export Markets, Shipment & Trade Details
Atazanavi and Ritonavir Tablet IP enjoys robust demand in both domestic and international markets. Shipped goods are processed efficiently from our main FOB ports, with a strong supply ability catering to exporters, dealers, and wholesalers. Our comprehensive charge structure offers competitive rates within the domestic marketplace, consolidating our position as a formidable player in pharmaceutical logistics and distribution for critical HIV medications.
FAQ's of Atazanavi and Ritonavir Tablet IP:
Q: How should Atazanavi and Ritonavir Tablet IP be administered?
A: Atazanavi and Ritonavir Tablet IP should be taken orally as prescribed by a healthcare professional, typically as part of a combination antiretroviral regimen. Follow your doctor's instructions for optimal dosing.Q: What are the main features of this tablet?
A: This medicine is a fixed-dose combination of two acclaimed HIV protease inhibitors: atazanavir and ritonavir, designed to offer a formidable approach to HIV therapy. The tablets are yellow, capsule-shaped, and film-coated for ease of administration.Q: When should this medication be avoided?
A: Do not use Atazanavi and Ritonavir Tablet IP if you have a known hypersensitivity to atazanavir or ritonavir, or if you have severe hepatic impairment. Always consult your doctor before starting this therapy.Q: Where should I store these tablets?
A: Store the tablets in their original, tightly closed packaging below 30C, protected from moisture, to maintain their sterility and effectiveness throughout the 24-month shelf life.Q: What is the process for exporting or purchasing as a dealer or supplier?
A: Dealers, distributors, exporters, and wholesalers can charge and receive shipments through main FOB ports in India. Our supply chain ensures reliable, domestically and internationally shipped goods, meeting strict compliance and demand.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'HIV Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
